person · Reporting owner

Geist Wyatt D.

Disclosed activity across 1 company

Tapewire entity: 49611
SEC CIK: 0002080676

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Tenon Medical, Inc.TNON · Entity 2063	Chief Innovation Officer	May 01, 2026	May 05, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Tenon Medical, Inc.

Report date May 01, 2026 · Filed May 05, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common stockSEC Table I · non-derivative	IndirectBy SiVantage, Inc.	487,166	Reported balance After 2026-05-01 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2026-05-01 · Grant · Acquired 136,401 · Balance 487,166 F1: On May 1, 2026, Tenon Medical, Inc. ("Registrant") issued 276,228 shares of its common stock to SiVantage, Inc. ("SiVantage") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage, in connection with the achievement of a certain milestone set forth therein. The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage based on the reporting person's 49.38% equity interest in SiVantage. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.
Common stockSEC Table I · non-derivative	Direct	157,569	Reported balance Holding disclosure · report date 2026-05-01 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 157,569

Filing footnotes · ownership attribution and instrument terms

F1: On May 1, 2026, Tenon Medical, Inc. ("Registrant") issued 276,228 shares of its common stock to SiVantage, Inc. ("SiVantage") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage, in connection with the achievement of a certain milestone set forth therein. The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage based on the reporting person's 49.38% equity interest in SiVantage. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 01, 2026 Filed May 5, 2026 23:42 UTC	Tenon Medical, Inc. TNON · Entity 2063	GrantCommon stock	136,401	$0.00	$0.00	Disclosure SEC source: 0001213900-26-052437 · ownership.xml · nonDerivative · entry 1 Geist Wyatt D. · CIK 0002080676 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By SiVantage, Inc. Disclosed balance after: 487,166 F1 · ownership.nature: On May 1, 2026, Tenon Medical, Inc. ("Registrant") issued 276,228 shares of its common stock to SiVantage, Inc. ("SiVantage") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage, in connection with the achievement of a certain milestone set forth therein. The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage based on the reporting person's 49.38% equity interest in SiVantage. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest. Read SEC document
November 14, 2025 Filed Nov 19, 2025 01:01 UTC	Tenon Medical, Inc. TNON · Entity 2063	PurchaseCommon Stock Purchase Warrant · Derivative	19,455	Not disclosed Strike: $1.16	Not disclosed	Disclosure SEC source: 0001213900-25-112296 · ownership.xml · derivative · entry 3 Geist Wyatt D. · CIK 0002080676 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,455 Underlying: Common Stock · 19,455 shares Expires 2028-11-14 F1 · price: On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 19,455 shares of common stock of the Issuer and warrants to purchase up to 19,455 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025. Read SEC document
November 14, 2025 Filed Nov 19, 2025 01:01 UTC	Tenon Medical, Inc. TNON · Entity 2063	PurchaseCommon stock	19,455	Not disclosed	Not disclosed	Disclosure SEC source: 0001213900-25-112296 · ownership.xml · nonDerivative · entry 1 Geist Wyatt D. · CIK 0002080676 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,569 F1 · price: On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 19,455 shares of common stock of the Issuer and warrants to purchase up to 19,455 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.